Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 8, 1997, Pages 819-825

  Forestier, E ^a   Gustafsson, G ^a   Von Heideman, A ^b   Heim, S ^b   Hernell, O ^a   Mitelman, F ^b   Nordenson, I ^c   Swolin, B ^d   Soderhall S ^e  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Childhood lymphoblastic leukaemia; Cytogenetics; Event free survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; FEMALE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SWEDEN;

EID: 0030822781     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb08604.x     Document Type: Article

References (28)

1. Pui CH. Childhood leukemias. N Engl J Med 1995; 332: 1618-30
2. Pui CH, Crist WM. Treatment of childhood leukemias. Curr Opin Oncol 1995; 7: 36-44
3. Secker-Walker LM, Lawler SD, Hardisty RM. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 1978; 2: 1529-30
4. Williams DL, Tsiatis A, Brodeur GM, et al: Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 1982; 60: 864-71
5. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449-63
6. ISCN. An international system for human cytogenetic nomenclature. Basel: Karger, 1985
7. Nourusis MJ. SPSS statistical software. Chicago: SPSS Inc., 1994
8. Cox DR. Regression models and life tables. J Royal Stat Soc (B) 1972; 34: 187-220
9. Rubin CM, Le Beau MM, Mick R, et al. Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol 1991; 9: 2183-92
10. Rubin CM, Le Beau MM. Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1991; 13: 202-16.
11. Groupe Français de Cytogénélique Hématologique. Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 1993; 7: 10-9
12. Heerema NA, Palmer CG, Weetman R, et al. Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia. Leukemia 6: 185-92, 1992
13. Raimondi SC, Pui CH, Hancock ML, et al. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 1996; 10: 213-24
14. Trueworthy R, Shuster J, Look AT, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 1992; 10: 606-13
15. Raimondi SC, Robertson PK, Pui C-H, et al. Hyperdiploid (47-50) acute lymphoblastic leukemia in children. Blood 1992; 79: 3245-52
16. Look AT, Robertson PK, Williams DL, el al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985; 65: 1079-86
17. Whitehead VM, Vuchich MJ, Lauer SJ, et al. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (> 50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 1992; 80: 1316-23
18. Smets LA, Homan-Blok J, Hart A, et al: Prognostic implication of hyperdiploidy as based on DNA flow cytometric measurement in childhood acule lymphocytic leukemia-a multicenter study. Leukemia 1987; 1: 163-6
19. Jackson JF, Boyett J, Pullen J, et al. Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group study. Cancer 1990; 66: 1183-9
20. Harris MB, Shuste JJ, Caroll A, et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study. Blood 1992; 79: 3316-24
21. Raimondi SC, Pui CH, Head D, et al. Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemia. Leukemia 1992; 3: 171-5
22. Slørdahl SH, Gustafsson G, Jonmundsson G, et al. A NOPHO study. Down's syndrome (DS) and acute myelogenous leukemia (AML). A population based study in the live Nordic countries. Med Pediatr Oncol 1992; 20: 373
23. Pui C-H, Raimondi SC, Dodge RK, et al. Prognostic importance of structural abnormalities in children with hyperdiploid (> 50 chromosomes) acute lymphoblastic leukemia. Blood 1989; 73: 1963-7
24. Fletcher JA, Kimball VM, Lynch E, et al. Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood 1989; 74: 2130-5
25. Lampert F, Harbott J, Ritterbach J, et al. Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy. Cancer Genet Cytogenet 1991; 54: 277-9
26. Raimondi SC, Pui CH, Head DR, et al: Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia. Blood 1993; 82: 576-80
27. Rivera GK, Pinkel D, Simone JV, et al. Treatment of acute lymphoblastic leukemia. N Engl J Med YEAR?; 329: 1289-95
28. Mahmond H, Caroll AJ, Behm F, et al. The non-random die (9:12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and exellent prognosis. Leukemia 1992; 6: 703-7